Amgen Inc. buy Royal Bank of Canada
Start price
24.01.25
/
50%
€262.90
Target price
24.01.26
€308.19
Performance (%)
17.02%
Price
16:21
€298.25
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 17.02%. A total of €9.41 was paid as dividends for this prediction. This prediction currently runs until 24.01.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.016% | 4.016% |
| iShares Core DAX® | -1.933% | 2.239% |
| iShares Nasdaq 100 | -0.972% | 0.226% |
| iShares Nikkei 225® | -2.056% | 5.685% |
| iShares S&P 500 | -1.185% | 0.867% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $324.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat